Federal Circuit revives Orexo’s opiate patent suit against Teva

11-09-2018

Federal Circuit revives Orexo’s opiate patent suit against Teva

ADragan / iStockphoto.com

The US Court of Appeals for the Federal Circuit yesterday revived a patent infringement lawsuit against Teva Pharmaceuticals, in a win for Sweden-based Orexo.


Teva, Orexo, Actavis, generic drugs, opiate treatment, Zubsolv, patent infringement, patent invalidation, obviousness, prior art, Suboxone

LSIPR